CRI’s report puts forth that the global clinical trials support services market would register growth at a CAGR of 7.84% during the forecast phase of 2022-2028.
The rise in the incidence of diseases has majorly increased the demand for clinical trials support services, which is expected to drive the market growth. Further, the efficiency of support services in overcoming the barriers encountered while conducting clinical trials is another key factor supporting growth.
On the other hand, the delays in receiving regulatory approval for carrying out clinical trials due to stringent regulations are hindering the growth process. Moreover, the disadvantages associated with the use of open-source software are also negatively impacting market progress.
However, the increasing demand for pharmaceuticals & vaccines, along with the growing number of strategic acquisitions by market players, are expected to open up new growth opportunities for the clinical trial support services market.

REGIONAL OUTLOOK

The global market for clinical trials support services encompasses North America, Europe, the Asia-Pacific, Latin America, and the Middle East and Africa.
North America is the leading region in the global market, and held the largest market share in 2021. Most key players in the clinical trials support services market, such as IQVIA, Parexel, and Charles River Laboratories, among others, are based in the United States. This largely benefits the North American market.
Whereas, the high population of the Asia-Pacific, especially Asia, adds an advantage to the market in this region. This is because researchers gain access to a large number of potential trial participants. The Asia-Pacific is expected to witness the fastest growth in the global market over the considered period.

COMPETITIVE OUTLOOK

The leading players profiled in the global clinical trials support services market report include Charles River Laboratories, Advanced Clinical, WuXi AppTec, Parexel, IQVIA, Clinipace, PSI CRO, Worldwide Clinical Trials, Labcorp Drug Development, KCR, ICON Plc, Alcura, Medpace, CTI Clinical Trial and Consulting Services Inc, and Syneos Health.
Worldwide Clinical Trials is a globally leading contract research organization (CRO) that is invested in various therapeutic areas, such as cardiovascular, oncology, neuroscience, metabolic, and rare disease.
It offers several services, such as early phase/phase I development, phase II b-III clinical trials, phase III b- phase IV clinical trials, etc. Biostatistics services offered by the organization comprise statistical analysis plan development, sample size estimation & methodology review, rapid reporting, and data delivery. Founded in 1986, Worldwide Clinical Trials has a business presence in North America, Asia-Pacific, Latin America, and Europe.

TABLE OF CONTENTS

1. GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE CLINICAL TRIALS SUPPORT SERVICES MARKET
2.2. KEY INSIGHTS
2.2.1. KEY PLAYERS’ PROMISING COLLABORATIONS
2.2.2. INCREASE IN SCREENING TESTS
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY BUYING IMPACT ANALYSIS
2.4.1. PERFORMANCE
2.4.2. EASE OF USE
2.4.3. SECURITY
2.4.4. COST EFFECTIVENESS
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. REGULATORY FRAMEWORK
2.9. KEY MARKET STRATEGIES
2.9.1. ACQUISITIONS
2.9.2. PRODUCT LAUNCHES
2.9.3. CONTRACTS & AGREEMENTS
2.9.4. INVESTMENTS & EXPANSIONS
2.10. MARKET DRIVERS
2.10.1. NEED TO OVERCOME THE BARRIERS IN CLINICAL TRIALS
2.10.2. RISE IN TRIALS DUE TO INCREASED DISEASE INCIDENCE
2.11. MARKET CHALLENGES
2.11.1. DELAYED APPROVAL DUE TO STRINGENT REGULATORY FRAMEWORK
2.11.2. USE OF OPEN-SOURCE SOFTWARE
2.12. MARKET OPPORTUNITIES
2.12.1. INCREASING DEMAND FOR VACCINES AND PHARMACEUTICALS
2.12.2. DATA MANAGEMENT SERVICE EXPECTED TO WITNESS NOTABLE GROWTH
2.12.3. ACQUISITIONS IN THE CLINICAL TRIALS SUPPORT SERVICES MARKET
3. GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY PHASE TYPE
3.1. PHASE I
3.2. PHASE II
3.3. PHASE III
3.4. PHASE IV
4. GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SERVICE
4.1. CLINICAL TRIAL SITE MANAGEMENT
4.2. ADMINISTRATIVE SERVICES
4.3. PATIENT RECRUITMENT MANAGEMENT
4.4. REGULATORY SERVICES
4.5. DATA MANAGEMENT
4.6. OTHER SERVICES
5. GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SPONSOR
5.1. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
5.2. MEDICAL DEVICE COMPANIES
5.3. OTHER SPONSORS
6. GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET – REGIONAL OUTLOOK
6.1. NORTH AMERICA
6.1.1. MARKET OUTLOOK BY SERVICE
6.1.2. MARKET OUTLOOK BY PHASE TYPE
6.1.3. MARKET OUTLOOK BY SPONSOR
6.1.4. COUNTRY ANALYSIS
6.1.4.1. UNITED STATES
6.1.4.2. CANADA
6.2. EUROPE
6.2.1. MARKET OUTLOOK BY SERVICE
6.2.2. MARKET OUTLOOK BY PHASE TYPE
6.2.3. MARKET OUTLOOK BY SPONSOR
6.2.4. COUNTRY ANALYSIS
6.2.4.1. UNITED KINGDOM
6.2.4.2. GERMANY
6.2.4.3. FRANCE
6.2.4.4. SPAIN
6.2.4.5. ITALY
6.2.4.6. REST OF EUROPE
6.3. ASIA-PACIFIC
6.3.1. MARKET OUTLOOK BY SERVICE
6.3.2. MARKET OUTLOOK BY PHASE TYPE
6.3.3. MARKET OUTLOOK BY SPONSOR
6.3.4. COUNTRY ANALYSIS
6.3.4.1. CHINA
6.3.4.2. JAPAN
6.3.4.3. INDIA
6.3.4.4. SOUTH KOREA
6.3.4.5. ASEAN COUNTRIES
6.3.4.6. AUSTRALIA & NEW ZEALAND
6.3.4.7. REST OF ASIA-PACIFIC
6.4. LATIN AMERICA
6.4.1. MARKET OUTLOOK BY SERVICE
6.4.2. MARKET OUTLOOK BY PHASE TYPE
6.4.3. MARKET OUTLOOK BY SPONSOR
6.4.4. COUNTRY ANALYSIS
6.4.4.1. BRAZIL
6.4.4.2. MEXICO
6.4.4.3. REST OF LATIN AMERICA
6.5. MIDDLE EAST AND AFRICA
6.5.1. MARKET OUTLOOK BY SERVICE
6.5.2. MARKET OUTLOOK BY PHASE TYPE
6.5.3. MARKET OUTLOOK BY SPONSOR
6.5.4. COUNTRY ANALYSIS
6.5.4.1. UNITED ARAB EMIRATES
6.5.4.2. SAUDI ARABIA
6.5.4.3. TURKEY
6.5.4.4. SOUTH AFRICA
6.5.4.5. REST OF MIDDLE EAST & AFRICA
7. COMPETITIVE LANDSCAPE
7.1. IQVIA
7.2. PAREXEL
7.3. ICON PLC
7.4. SYNEOS HEALTH
7.5. LABCORP DRUG DEVELOPMENT
7.6. CLINIPACE
7.7. KCR
7.8. CHARLES RIVER LABORATORIES
7.9. MEDPACE
7.10. ALCURA
7.11. PSI CRO
7.12. WORLDWIDE CLINICAL TRIALS
7.13. CTI CLINICAL TRIAL AND CONSULTING SERVICES INC
7.14. WUXI APPTEC
7.15. ADVANCED CLINICAL
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY

TABLE LIST

TABLE 1: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: LIST OF COLLABORATIONS
TABLE 3: VENDOR SCORECARD
TABLE 4: REGULATORY FRAMEWORK
TABLE 5: LIST OF ACQUISITIONS
TABLE 6: LIST OF PRODUCT LAUNCHES
TABLE 7: LIST OF CONTRACTS & AGREEMENTS
TABLE 8: LIST OF INVESTMENTS & BUSINESS EXPANSIONS
TABLE 9: LIST OF PANDEMIC OUTBREAKS
TABLE 10: LIST OF OPEN-SOURCE SOFTWARE
TABLE 11: LAUNCH OF MEDICAL DRUGS
TABLE 12: PROMISING ACQUISITIONS IN THE MARKET
TABLE 13: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 14: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 15: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 16: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 17: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 18: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 19: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 20: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 21: NUMBER AND TYPES OF REGISTERED STUDIES
TABLE 22: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 23: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 24: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 25: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 26: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 27: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 28: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 29: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 30: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 31: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 32: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 33: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 34: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 35: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 36: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 37: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2021 & 2028 (IN %)
FIGURE 5: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2028 (IN $ MILLION)
FIGURE 6: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2028 (IN $ MILLION)
FIGURE 7: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2028 (IN $ MILLION)
FIGURE 8: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2028 (IN $ MILLION)
FIGURE 9: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2021 & 2028 (IN %)
FIGURE 10: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 11: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 12: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 13: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGULATORY SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 14: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 15: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 16: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2021 & 2028 (IN %)
FIGURE 17: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 18: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 19: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS, 2022-2028 (IN $ MILLION)
FIGURE 20: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, REGIONAL OUTLOOK, 2021 & 2028 (IN %)
FIGURE 21: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 22: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: CANADA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 25: UNITED KINGDOM CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: GERMANY CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 27: FRANCE CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 28: SPAIN CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 29: ITALY CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 30: REST OF EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 31: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 32: CHINA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 33: JAPAN CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 34: INDIA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 35: SOUTH KOREA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 36: ASEAN COUNTRIES CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 37: AUSTRALIA & NEW ZEALAND CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 38: REST OF ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 39: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 40: BRAZIL CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 41: MEXICO CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 42: REST OF LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 43: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 44: UNITED ARAB EMIRATES CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 45: SAUDI ARABIA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 46: TURKEY CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 47: SOUTH AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 48: REST OF MIDDLE EAST & AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

The post GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 first appeared on CRI Report.

According to this report, the market for clinical trials support services in North America is anticipated to develop with a CAGR of 7.39% in the forecasted period 2022-2028. The United States and Canada are assessed in the market in this region.
There are several companies based in the US that operate in this field and offer various solutions. For instance, IQVIA offers a clinical trial management system, Syneos Health offers a decentralized solutions team & clinical project management solutions, Charles River Laboratories offers zygosity testing, Parexel offers biostatistics services, and many other companies offer similar services. The presence of several leading companies is aiding the growth of the United States’ market.
In Canada, hundreds of new clinical trials pertaining to medical drugs, vaccines, and others, take place. The nation accounts for 4% of the total global clinical trials conducted, and ranks fourth with respect to the number of clinical trials sites. Besides, it is also the leader among G7 countries in terms of clinical trials productivity. These factors influence the demand for support services to conduct these trials. This, in turn, is expected to foster the growth of the Canadian clinical trials support services market. Besides, the market is benefited by the availability of a large participant pool, as children and youth can also partake in the trial process after obtaining permission from their parents or caretakers.

COMPETITIVE OUTLOOK

Charles River Laboratories, PSI CRO, Advanced Clinical, Worldwide Clinical Trials, WuXi AppTec, CTI Clinical Trial and Consulting Services Inc, KCR, and Syneos Health are some of the eminent players in the clinical trials support services market.

TABLE OF CONTENTS

1. NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE CLINICAL TRIALS SUPPORT SERVICES MARKET
2.2. KEY INSIGHTS
2.2.1. KEY PLAYERS’ PROMISING COLLABORATIONS
2.2.2. INCREASE IN SCREENING TESTS
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY BUYING IMPACT ANALYSIS
2.4.1. PERFORMANCE
2.4.2. EASE OF USE
2.4.3. SECURITY
2.4.4. COST EFFECTIVENESS
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. REGULATORY FRAMEWORK
2.9. KEY MARKET STRATEGIES
2.9.1. ACQUISITIONS
2.9.2. PRODUCT LAUNCHES
2.9.3. CONTRACTS & AGREEMENTS
2.9.4. INVESTMENTS & EXPANSIONS
2.10. MARKET DRIVERS
2.10.1. NEED TO OVERCOME THE BARRIERS IN CLINICAL TRIALS
2.10.2. RISE IN TRIALS DUE TO INCREASED DISEASE INCIDENCE
2.11. MARKET CHALLENGES
2.11.1. DELAYED APPROVAL DUE TO STRINGENT REGULATORY FRAMEWORK
2.11.2. USE OF OPEN-SOURCE SOFTWARE
2.12. MARKET OPPORTUNITIES
2.12.1. INCREASING DEMAND FOR VACCINES AND PHARMACEUTICALS
2.12.2. DATA MANAGEMENT SERVICE EXPECTED TO WITNESS NOTABLE GROWTH
2.12.3. ACQUISITIONS IN THE CLINICAL TRIALS SUPPORT SERVICES MARKET
3. NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY PHASE TYPE
3.1. PHASE I
3.2. PHASE II
3.3. PHASE III
3.4. PHASE IV
4. NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SERVICE
4.1. CLINICAL TRIAL SITE MANAGEMENT
4.2. ADMINISTRATIVE SERVICES
4.3. PATIENT RECRUITMENT MANAGEMENT
4.4. REGULATORY SERVICES
4.5. DATA MANAGEMENT
4.6. OTHER SERVICES
5. NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SPONSOR
5.1. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
5.2. MEDICAL DEVICE COMPANIES
5.3. OTHER SPONSORS
6. NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET – COUNTRY OUTLOOK
6.1. UNITED STATES
6.2. CANADA
7. COMPETITIVE LANDSCAPE
7.1. IQVIA
7.2. PAREXEL
7.3. ICON PLC
7.4. SYNEOS HEALTH
7.5. LABCORP DRUG DEVELOPMENT
7.6. CLINIPACE
7.7. KCR
7.8. CHARLES RIVER LABORATORIES
7.9. MEDPACE
7.10. ALCURA
7.11. PSI CRO
7.12. WORLDWIDE CLINICAL TRIALS
7.13. CTI CLINICAL TRIAL AND CONSULTING SERVICES INC
7.14. WUXI APPTEC
7.15. ADVANCED CLINICAL
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY

TABLE LIST

TABLE 1: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: LIST OF COLLABORATIONS
TABLE 3: VENDOR SCORECARD
TABLE 4: REGULATORY FRAMEWORK
TABLE 5: LIST OF ACQUISITIONS
TABLE 6: LIST OF PRODUCT LAUNCHES
TABLE 7: LIST OF CONTRACTS & AGREEMENTS
TABLE 8: LIST OF INVESTMENTS & BUSINESS EXPANSIONS
TABLE 9: LIST OF PANDEMIC OUTBREAKS
TABLE 10: LIST OF OPEN-SOURCE SOFTWARE
TABLE 11: LAUNCH OF MEDICAL DRUGS
TABLE 12: PROMISING ACQUISITIONS IN THE MARKET
TABLE 13: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 15: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 16: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 17: NUMBER AND TYPES OF REGISTERED STUDIES

FIGURE LIST

FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2021 & 2028 (IN %)
FIGURE 5: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2028 (IN $ MILLION)
FIGURE 6: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2021 & 2028 (IN %)
FIGURE 10: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 12: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGULATORY SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 14: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 15: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 16: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2021 & 2028 (IN %)
FIGURE 17: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 18: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 19: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS, 2022-2028 (IN $ MILLION)
FIGURE 20: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 21: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2028 (IN $ MILLION)
FIGURE 22: CANADA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2028 (IN $ MILLION)

The post NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 first appeared on CRI Report.

CRI’s report on the clinical trials support services market in the Middle East and Africa states that it is likely to develop with a CAGR of 7.20% during the forecast phase from 2022 to 2028. Turkey, South Africa, Saudi Arabia, the United Arab Emirates, and Rest of Middle East & Africa are evaluated in the market in this region.
Numerous different types of clinical research activities have been conducted in the United Arab Emirates in recent years. These are sponsored mainly by government-affiliated as well as private healthcare providers, and an increasing number of trials conducted in the UAE have been registered internationally. Further, academic grants, pharmaceutical sponsorships, and other endowments also account for clinical research funding in the nation.
According to the Department of Health officials, Abu Dhabi is well-positioned to become a leading destination for clinical trials, gaining the attention of leading multinational life sciences corporations due to its diverse population and strategic location. All these factors indicate an overall positive outlook for the clinical trials support services market.
Saudi Arabia conducts 15 trials per million people, compared to 341 trials per million people in the United States. Despite the large population, excellent healthcare infrastructure, and a high physician-to-patient ratio in the KSA, it still lags behind other countries with comparable economies in terms of clinical research. Saudi’s population has its own genetic characteristics. The key to attracting biotechnology and pharmaceutical companies is to concentrate on specific research areas of importance to the nation. This, in turn, would bolster the clinical trials conducted and drive the demand for support services.

COMPETITIVE OUTLOOK

Some of the acclaimed players in the clinical trials support services market include Worldwide Clinical Trials, Charles River Laboratories, WuXi AppTec, KCR, Alcura, Medpace, ICON Plc, and Advanced Clinical.

TABLE OF CONTENTS

1. MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE CLINICAL TRIALS SUPPORT SERVICES MARKET
2.2. KEY INSIGHTS
2.2.1. KEY PLAYERS’ PROMISING COLLABORATIONS
2.2.2. INCREASE IN SCREENING TESTS
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY BUYING IMPACT ANALYSIS
2.4.1. PERFORMANCE
2.4.2. EASE OF USE
2.4.3. SECURITY
2.4.4. COST EFFECTIVENESS
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. KEY MARKET STRATEGIES
2.8.1. ACQUISITIONS
2.8.2. PRODUCT LAUNCHES
2.8.3. CONTRACTS & AGREEMENTS
2.8.4. INVESTMENTS & EXPANSIONS
2.9. MARKET DRIVERS
2.9.1. NEED TO OVERCOME THE BARRIERS IN CLINICAL TRIALS
2.9.2. RISE IN TRIALS DUE TO INCREASED DISEASE INCIDENCE
2.10. MARKET CHALLENGES
2.10.1. DELAYED APPROVAL DUE TO STRINGENT REGULATORY FRAMEWORK
2.10.2. USE OF OPEN-SOURCE SOFTWARE
2.11. MARKET OPPORTUNITIES
2.11.1. INCREASING DEMAND FOR VACCINES AND PHARMACEUTICALS
2.11.2. DATA MANAGEMENT SERVICE EXPECTED TO WITNESS NOTABLE GROWTH
2.11.3. ACQUISITIONS IN THE CLINICAL TRIALS SUPPORT SERVICES MARKET
3. MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY PHASE TYPE
3.1. PHASE I
3.2. PHASE II
3.3. PHASE III
3.4. PHASE IV
4. MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SERVICE
4.1. CLINICAL TRIAL SITE MANAGEMENT
4.2. ADMINISTRATIVE SERVICES
4.3. PATIENT RECRUITMENT MANAGEMENT
4.4. REGULATORY SERVICES
4.5. DATA MANAGEMENT
4.6. OTHER SERVICES
5. MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SPONSOR
5.1. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
5.2. MEDICAL DEVICE COMPANIES
5.3. OTHER SPONSORS
6. MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET – COUNTRY OUTLOOK
6.1. UNITED ARAB EMIRATES
6.2. SAUDI ARABIA
6.3. TURKEY
6.4. SOUTH AFRICA
6.5. REST OF MIDDLE EAST & AFRICA
7. COMPETITIVE LANDSCAPE
7.1. IQVIA
7.2. PAREXEL
7.3. ICON PLC
7.4. SYNEOS HEALTH
7.5. LABCORP DRUG DEVELOPMENT
7.6. CLINIPACE
7.7. KCR
7.8. CHARLES RIVER LABORATORIES
7.9. MEDPACE
7.10. ALCURA
7.11. PSI CRO
7.12. WORLDWIDE CLINICAL TRIALS
7.13. CTI CLINICAL TRIAL AND CONSULTING SERVICES INC
7.14. WUXI APPTEC
7.15. ADVANCED CLINICAL
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY

TABLE LIST

TABLE 1: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: LIST OF COLLABORATIONS
TABLE 3: VENDOR SCORECARD
TABLE 4: LIST OF ACQUISITIONS
TABLE 5: LIST OF PRODUCT LAUNCHES
TABLE 6: LIST OF CONTRACTS & AGREEMENTS
TABLE 7: LIST OF INVESTMENTS & BUSINESS EXPANSIONS
TABLE 8: LIST OF PANDEMIC OUTBREAKS
TABLE 9: LIST OF OPEN-SOURCE SOFTWARE
TABLE 10: LAUNCH OF MEDICAL DRUGS
TABLE 11: PROMISING ACQUISITIONS IN THE MARKET
TABLE 12: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 13: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 14: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 15: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2021 & 2028 (IN %)
FIGURE 5: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2028 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2028 (IN $ MILLION)
FIGURE 7: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2028 (IN $ MILLION)
FIGURE 8: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2028 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2021 & 2028 (IN %)
FIGURE 10: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 11: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 12: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGULATORY SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 14: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 15: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 16: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2021 & 2028 (IN %)
FIGURE 17: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 18: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 19: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS, 2022-2028 (IN $ MILLION)
FIGURE 20: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 21: UNITED ARAB EMIRATES CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 22: SAUDI ARABIA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: TURKEY CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: SOUTH AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 25: REST OF MIDDLE EAST & AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

The post MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 first appeared on CRI Report.

The market for clinical trials support services in Latin America is predicted to exhibit growth, with a CAGR of 7.12% over the forecasting duration between 2022 and 2028. Brazil, Mexico, and Rest of Latin America are included in the market in this region.
Over the last decade, the number of clinical research activities being conducted in Brazil has grown at an exponential rate. The last three years, especially, have seen a significant increase. In 2021, the leading therapy area for industry-sponsored clinical trials in the country was infectious disease (accounting for the highest market share at 36.4%). This was followed by oncology (accounting for 23.1% of the market share), cardiovascular diseases (accounting for 7.1% of the market share), central nervous system disorders (accounting for a 7.1% market share), and metabolic disorders (which held a market share of 6.8%).
The growing number of clinical trials have called for the use of support services to conduct these trials more efficiently. This is expected to enhance the growth of the clinical trials support services market in the country. Besides, a number of companies operating in this field are now focusing on the Brazilian market. Additionally, the number of domestic players has also increased. For instance, Synova Health, a São Paulo-based company, offers clinical monitoring services, project management services, and others. This is expected to further contribute to market growth in the coming years.

COMPETITIVE OUTLOOK

Some of the distinguished players engaged in the clinical trials support services market include Syneos Health, IQVIA, CTI Clinical Trial and Consulting Services Inc, Medpace, Charles River Laboratories, ICON Plc, WuXi AppTec, and Clinipace.

TABLE OF CONTENTS

1. LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE CLINICAL TRIALS SUPPORT SERVICES MARKET
2.2. KEY INSIGHTS
2.2.1. KEY PLAYERS’ PROMISING COLLABORATIONS
2.2.2. INCREASE IN SCREENING TESTS
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY BUYING IMPACT ANALYSIS
2.4.1. PERFORMANCE
2.4.2. EASE OF USE
2.4.3. SECURITY
2.4.4. COST EFFECTIVENESS
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. KEY MARKET STRATEGIES
2.8.1. ACQUISITIONS
2.8.2. PRODUCT LAUNCHES
2.8.3. CONTRACTS & AGREEMENTS
2.8.4. INVESTMENTS & EXPANSIONS
2.9. MARKET DRIVERS
2.9.1. NEED TO OVERCOME THE BARRIERS IN CLINICAL TRIALS
2.9.2. RISE IN TRIALS DUE TO INCREASED DISEASE INCIDENCE
2.10. MARKET CHALLENGES
2.10.1. DELAYED APPROVAL DUE TO STRINGENT REGULATORY FRAMEWORK
2.10.2. USE OF OPEN-SOURCE SOFTWARE
2.11. MARKET OPPORTUNITIES
2.11.1. INCREASING DEMAND FOR VACCINES AND PHARMACEUTICALS
2.11.2. DATA MANAGEMENT SERVICE EXPECTED TO WITNESS NOTABLE GROWTH
2.11.3. ACQUISITIONS IN THE CLINICAL TRIALS SUPPORT SERVICES MARKET
3. LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY PHASE TYPE
3.1. PHASE I
3.2. PHASE II
3.3. PHASE III
3.4. PHASE IV
4. LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SERVICE
4.1. CLINICAL TRIAL SITE MANAGEMENT
4.2. ADMINISTRATIVE SERVICES
4.3. PATIENT RECRUITMENT MANAGEMENT
4.4. REGULATORY SERVICES
4.5. DATA MANAGEMENT
4.6. OTHER SERVICES
5. LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SPONSOR
5.1. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
5.2. MEDICAL DEVICE COMPANIES
5.3. OTHER SPONSORS
6. LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET – COUNTRY OUTLOOK
6.1. BRAZIL
6.2. MEXICO
6.3. REST OF LATIN AMERICA
7. COMPETITIVE LANDSCAPE
7.1. IQVIA
7.2. PAREXEL
7.3. ICON PLC
7.4. SYNEOS HEALTH
7.5. LABCORP DRUG DEVELOPMENT
7.6. CLINIPACE
7.7. KCR
7.8. CHARLES RIVER LABORATORIES
7.9. MEDPACE
7.10. ALCURA
7.11. PSI CRO
7.12. WORLDWIDE CLINICAL TRIALS
7.13. CTI CLINICAL TRIAL AND CONSULTING SERVICES INC
7.14. WUXI APPTEC
7.15. ADVANCED CLINICAL
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY

TABLE LIST

TABLE 1: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: LIST OF COLLABORATIONS
TABLE 3: VENDOR SCORECARD
TABLE 4: LIST OF ACQUISITIONS
TABLE 5: LIST OF PRODUCT LAUNCHES
TABLE 6: LIST OF CONTRACTS & AGREEMENTS
TABLE 7: LIST OF INVESTMENTS & BUSINESS EXPANSIONS
TABLE 8: LIST OF PANDEMIC OUTBREAKS
TABLE 9: LIST OF OPEN-SOURCE SOFTWARE
TABLE 10: LAUNCH OF MEDICAL DRUGS
TABLE 11: PROMISING ACQUISITIONS IN THE MARKET
TABLE 12: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 13: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 14: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 15: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2021 & 2028 (IN %)
FIGURE 5: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2028 (IN $ MILLION)
FIGURE 6: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2028 (IN $ MILLION)
FIGURE 7: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2028 (IN $ MILLION)
FIGURE 8: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2028 (IN $ MILLION)
FIGURE 9: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2021 & 2028 (IN %)
FIGURE 10: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 11: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 12: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 13: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGULATORY SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 14: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 15: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 16: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2021 & 2028 (IN %)
FIGURE 17: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 18: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 19: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS, 2022-2028 (IN $ MILLION)
FIGURE 20: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 21: BRAZIL CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 22: MEXICO CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: REST OF LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

The post LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 first appeared on CRI Report.

CRI’s study estimates the clinical trials support services market in Europe to grow with a CAGR of 8.15% during the forecast years 2022-2028. Italy, Spain, Germany, the United Kingdom, France, and Rest of Europe are analyzed in the market in this region.
Countries like Poland, Ireland, Austria, Switzerland, and others, are covered under Rest of Europe. In Poland, the number of clinical trials being performed has increased significantly. For instance, from 2000 to 2019, 1840 clinical trials took place in Poland. The increase in the number of trials also increases the amount of data generated. This calls for the adoption of support services such as data management, data processing, data analysis, etc. The increased use of support services is expected to drive the growth of the studied market in Poland, and, in turn, in Rest of Europe.
Spain ranks first in Europe and fourth in the world in terms of conducting clinical trials. The collaboration between the private and public sectors has contributed in making the country a leading name in the clinical trials sector. 1,019 trials were approved in 2020, of which 34% share was captured by medicines for treating various types of cancer. The major factor driving successful clinical trials is the involvement of an increasing number of patients in the trial process. For instance, in 2021, nearly 145,000 patients participated in more than 3,400 ongoing clinical trials in Spain.

COMPETITIVE OUTLOOK

The noteworthy players in the clinical trials support services market include IQVIA, ICON Plc, CTI Clinical Trial and Consulting Services Inc, Charles River Laboratories, PSI CRO, WuXi AppTec, Worldwide Clinical Trials, and Parexel.

TABLE OF CONTENTS

1. EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE CLINICAL TRIALS SUPPORT SERVICES MARKET
2.2. KEY INSIGHTS
2.2.1. KEY PLAYERS’ PROMISING COLLABORATIONS
2.2.2. INCREASE IN SCREENING TESTS
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY BUYING IMPACT ANALYSIS
2.4.1. PERFORMANCE
2.4.2. EASE OF USE
2.4.3. SECURITY
2.4.4. COST EFFECTIVENESS
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. REGULATORY FRAMEWORK
2.9. KEY MARKET STRATEGIES
2.9.1. ACQUISITIONS
2.9.2. PRODUCT LAUNCHES
2.9.3. CONTRACTS & AGREEMENTS
2.9.4. INVESTMENTS & EXPANSIONS
2.10. MARKET DRIVERS
2.10.1. NEED TO OVERCOME THE BARRIERS IN CLINICAL TRIALS
2.10.2. RISE IN TRIALS DUE TO INCREASED DISEASE INCIDENCE
2.11. MARKET CHALLENGES
2.11.1. DELAYED APPROVAL DUE TO STRINGENT REGULATORY FRAMEWORK
2.11.2. USE OF OPEN-SOURCE SOFTWARE
2.12. MARKET OPPORTUNITIES
2.12.1. INCREASING DEMAND FOR VACCINES AND PHARMACEUTICALS
2.12.2. DATA MANAGEMENT SERVICE EXPECTED TO WITNESS NOTABLE GROWTH
2.12.3. ACQUISITIONS IN THE CLINICAL TRIALS SUPPORT SERVICES MARKET
3. EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY PHASE TYPE
3.1. PHASE I
3.2. PHASE II
3.3. PHASE III
3.4. PHASE IV
4. EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SERVICE
4.1. CLINICAL TRIAL SITE MANAGEMENT
4.2. ADMINISTRATIVE SERVICES
4.3. PATIENT RECRUITMENT MANAGEMENT
4.4. REGULATORY SERVICES
4.5. DATA MANAGEMENT
4.6. OTHER SERVICES
5. EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SPONSOR
5.1. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
5.2. MEDICAL DEVICE COMPANIES
5.3. OTHER SPONSORS
6. EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET – COUNTRY OUTLOOK
6.1. UNITED KINGDOM
6.2. GERMANY
6.3. FRANCE
6.4. SPAIN
6.5. ITALY
6.6. REST OF EUROPE
7. COMPETITIVE LANDSCAPE
7.1. IQVIA
7.2. PAREXEL
7.3. ICON PLC
7.4. SYNEOS HEALTH
7.5. LABCORP DRUG DEVELOPMENT
7.6. CLINIPACE
7.7. KCR
7.8. CHARLES RIVER LABORATORIES
7.9. MEDPACE
7.10. ALCURA
7.11. PSI CRO
7.12. WORLDWIDE CLINICAL TRIALS
7.13. CTI CLINICAL TRIAL AND CONSULTING SERVICES INC
7.14. WUXI APPTEC
7.15. ADVANCED CLINICAL
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY

TABLE LIST

TABLE 1: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: LIST OF COLLABORATIONS
TABLE 3: VENDOR SCORECARD
TABLE 4: REGULATORY FRAMEWORK
TABLE 5: LIST OF ACQUISITIONS
TABLE 6: LIST OF PRODUCT LAUNCHES
TABLE 7: LIST OF CONTRACTS & AGREEMENTS
TABLE 8: LIST OF INVESTMENTS & BUSINESS EXPANSIONS
TABLE 9: LIST OF PANDEMIC OUTBREAKS
TABLE 10: LIST OF OPEN-SOURCE SOFTWARE
TABLE 11: LAUNCH OF MEDICAL DRUGS
TABLE 12: PROMISING ACQUISITIONS IN THE MARKET
TABLE 13: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 14: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 15: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 16: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2021 & 2028 (IN %)
FIGURE 5: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2028 (IN $ MILLION)
FIGURE 6: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2028 (IN $ MILLION)
FIGURE 7: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2028 (IN $ MILLION)
FIGURE 8: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2028 (IN $ MILLION)
FIGURE 9: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2021 & 2028 (IN %)
FIGURE 10: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 11: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 12: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 13: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGULATORY SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 14: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 15: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 16: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2021 & 2028 (IN %)
FIGURE 17: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 18: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 19: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS, 2022-2028 (IN $ MILLION)
FIGURE 20: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 21: UNITED KINGDOM CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 22: GERMANY CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: FRANCE CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: SPAIN CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 25: ITALY CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: REST OF EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

The post EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 first appeared on CRI Report.

A report by CRI depicts that the market for clinical trials support services in the Asia-Pacific would advance with a CAGR of 8.41% over the projected phase from 2022 to 2028. Japan, ASEAN countries, India, Australia & New Zealand, China, South Korea, and Rest of Asia-Pacific are scrutinized in the market in this region.
Japan has developed its infrastructure for clinical trials. Now, several major pharmaceutical companies or CROs are increasingly choosing it as a preferred location to conduct clinical trials. This is because the regulatory frameworks in the country now align with the timelines of drug approval in the US and Europe. Apart from leading multinationals, domestic players are also offering support services for conducting clinical trials in Japan. With the improvement in the regulatory guidelines, the bar for conducting clinical trials in Japan has risen. These developments indicate an overall positive outlook for the Japanese market.
Even in India, there are a number of domestic contract research organizations (CROs) that offer support services for clinical trials. For instance, Abiogenesis Clinpharm is a leading name in the field of support services for clinical trials of drugs, nutraceuticals, vaccines, medical devices, biosimilars, and herbal products. It offers services such as clinical operations, biostatistics, data management, site management services, and so forth. Another company, Accutest Research Laboratories, is a global independent and internationally accredited CRO. It offers bioanalytical services, assistance for seeking regulatory approvals, and customized studies for challenging drugs that require complex designs, while also ensuring special attention to safety parameters. Thus, the presence of dedicated domestic players is strengthening the growth of the Indian market.

COMPETITIVE OUTLOOK

The notable companies in the clinical trials support services market are Syneos Health, CTI Clinical Trial and Consulting Services Inc, WuXi AppTec, ICON Plc, Charles River Laboratories, Parexel, PSI CRO, and Clinipace.

TABLE OF CONTENTS

1. ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE CLINICAL TRIALS SUPPORT SERVICES MARKET
2.2. KEY INSIGHTS
2.2.1. KEY PLAYERS’ PROMISING COLLABORATIONS
2.2.2. INCREASE IN SCREENING TESTS
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY BUYING IMPACT ANALYSIS
2.4.1. PERFORMANCE
2.4.2. EASE OF USE
2.4.3. SECURITY
2.4.4. COST EFFECTIVENESS
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. REGULATORY FRAMEWORK
2.9. KEY MARKET STRATEGIES
2.9.1. ACQUISITIONS
2.9.2. PRODUCT LAUNCHES
2.9.3. CONTRACTS & AGREEMENTS
2.9.4. INVESTMENTS & EXPANSIONS
2.10. MARKET DRIVERS
2.10.1. NEED TO OVERCOME THE BARRIERS IN CLINICAL TRIALS
2.10.2. RISE IN TRIALS DUE TO INCREASED DISEASE INCIDENCE
2.11. MARKET CHALLENGES
2.11.1. DELAYED APPROVAL DUE TO STRINGENT REGULATORY FRAMEWORK
2.11.2. USE OF OPEN-SOURCE SOFTWARE
2.12. MARKET OPPORTUNITIES
2.12.1. INCREASING DEMAND FOR VACCINES AND PHARMACEUTICALS
2.12.2. DATA MANAGEMENT SERVICE EXPECTED TO WITNESS NOTABLE GROWTH
2.12.3. ACQUISITIONS IN THE CLINICAL TRIALS SUPPORT SERVICES MARKET
3. ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY PHASE TYPE
3.1. PHASE I
3.2. PHASE II
3.3. PHASE III
3.4. PHASE IV
4. ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SERVICE
4.1. CLINICAL TRIAL SITE MANAGEMENT
4.2. ADMINISTRATIVE SERVICES
4.3. PATIENT RECRUITMENT MANAGEMENT
4.4. REGULATORY SERVICES
4.5. DATA MANAGEMENT
4.6. OTHER SERVICES
5. ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SPONSOR
5.1. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
5.2. MEDICAL DEVICE COMPANIES
5.3. OTHER SPONSORS
6. ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET – COUNTRY OUTLOOK
6.1. CHINA
6.2. JAPAN
6.3. INDIA
6.4. SOUTH KOREA
6.5. ASEAN COUNTRIES
6.6. AUSTRALIA & NEW ZEALAND
6.7. REST OF ASIA-PACIFIC
7. COMPETITIVE LANDSCAPE
7.1. IQVIA
7.2. PAREXEL
7.3. ICON PLC
7.4. SYNEOS HEALTH
7.5. LABCORP DRUG DEVELOPMENT
7.6. CLINIPACE
7.7. KCR
7.8. CHARLES RIVER LABORATORIES
7.9. MEDPACE
7.10. ALCURA
7.11. PSI CRO
7.12. WORLDWIDE CLINICAL TRIALS
7.13. CTI CLINICAL TRIAL AND CONSULTING SERVICES INC
7.14. WUXI APPTEC
7.15. ADVANCED CLINICAL
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY

TABLE LIST

TABLE 1: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: LIST OF COLLABORATIONS
TABLE 3: VENDOR SCORECARD
TABLE 4: REGULATORY FRAMEWORK
TABLE 5: LIST OF ACQUISITIONS
TABLE 6: LIST OF PRODUCT LAUNCHES
TABLE 7: LIST OF CONTRACTS & AGREEMENTS
TABLE 8: LIST OF INVESTMENTS & BUSINESS EXPANSIONS
TABLE 9: LIST OF PANDEMIC OUTBREAKS
TABLE 10: LIST OF OPEN-SOURCE SOFTWARE
TABLE 11: LAUNCH OF MEDICAL DRUGS
TABLE 12: PROMISING ACQUISITIONS IN THE MARKET
TABLE 13: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 14: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 16: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2021 & 2028 (IN %)
FIGURE 5: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2028 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2028 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2028 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2021 & 2028 (IN %)
FIGURE 10: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGULATORY SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2021 & 2028 (IN %)
FIGURE 17: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS, 2022-2028 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 21: CHINA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 22: JAPAN CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: INDIA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: SOUTH KOREA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 25: ASEAN COUNTRIES CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: AUSTRALIA & NEW ZEALAND CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 27: REST OF ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

The post ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 first appeared on CRI Report.

According to CRI’s report, the UAV battery market in North America is estimated to attain a CAGR of 17.54% over the forecasted years from 2022 to 2028. Canada and the United States are studied in this region.
In Canada, the introduction of UAVs in the aeronautical sector has offered various benefits to operators and end-users. Several companies have entered partnerships and contracts to offer product differentiation and enhancement. This has led to the rise in drones for monitoring, surveillance, and training purposes over the past few years. Such developments are thus expected to increase the need for batteries, thereby driving the UAV battery market on a progressive path.
Likewise, various companies have enhanced operations to gain a competitive edge in the UAV sector in the US. As a result, companies are able to gain contracts in the defense industry. Besides, numerous businesses are striving to enter the commercial segment. For instance, Amazon’s testing and research of unmanned aerial vehicles for logistics and delivery purposes have pressured the government to modify drone regulations. This is expected to increase drone demand for various applications, including agriculture, public safety, and disaster management. Thus, these factors are creating opportunities for the UAV battery market.

COMPETITIVE OUTLOOK

The leading companies in the UAV battery market include Plug Power, HES Energy Systems, Sion Power, Shenzhen Grepow Battery, Epsilor, and RRC Power Solutions.

TABLE OF CONTENTS

1. NORTH AMERICA UAV BATTERY MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE UAV BATTERY MARKET
2.2. KEY INSIGHTS
2.2.1. ADVANCEMENTS IN FUEL CELL TECHNOLOGY
2.2.2. MILITARY INVESTMENTS AND INITIATIVES IN THE UAV SECTOR
2.2.3. POPULARITY OF DRONES IN THE COMMERCIAL INDUSTRY
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. INDUSTRY COMPONENTS
2.7. REGULATORY FRAMEWORK
2.7.1. U.S. REGULATION
2.7.2. OTHER INTERNATIONAL REGULATIONS:
2.8. KEY MARKET STRATEGIES
2.8.1. ACQUISITIONS
2.8.2. PRODUCT LAUNCHES
2.8.3. INVESTMENTS & EXPANSIONS
2.9. MARKET DRIVERS
2.9.1. DEVELOPMENTS IN SMART BATTERY TECHNOLOGY
2.9.2. ONGOING RESEARCH AND DEVELOPMENTS IN UAV AND ADJACENT INDUSTRIES
2.9.3. GROWING NEED FOR LONG-RANGE UAVS WITH HIGH PAYLOAD CAPACITY
2.10. MARKET CHALLENGES
2.10.1. ISSUES DUE TO THERMAL RUNAWAY
2.10.2. REGULATIONS AGAINST TRANSPORT OF UAV BATTERIES
2.11. MARKET OPPORTUNITIES
2.11.1. ADOPTION OF UAVS ACROSS VARIOUS SECTORS
2.11.2. INNOVATIONS IN WIRELESS CHARGING TECHNOLOGY
3. NORTH AMERICA UAV BATTERY MARKET OUTLOOK – BY PRODUCT TYPE
3.1. LITHIUM-BASED
3.2. NICKEL-BASED
3.3. FUEL CELL
4. NORTH AMERICA UAV BATTERY MARKET OUTLOOK – BY UAV MODEL
4.1. FIXED-WING
4.2. ROTARY-WING
4.3. FIXED-WING VTOL (HYBRID)
5. NORTH AMERICA UAV BATTERY MARKET OUTLOOK – BY INDUSTRY VERTICAL
5.1. CONSUMER
5.2. COMMERCIAL
5.3. DEFENSE, GOVERNMENT, & LAW ENFORCEMENT
6. NORTH AMERICA UAV BATTERY MARKET – COUNTRY OUTLOOK
6.1. UNITED STATES
6.2. CANADA
7. COMPETITIVE LANDSCAPE
7.1. PLUG POWER
7.2. INTELLIGENT ENERGY
7.3. HES ENERGY SYSTEMS
7.4. RRC POWER SOLUTIONS
7.5. SION POWER
7.6. EAGLE PICHER TECHNOLOGIES
7.7. INVENTUS POWER
7.8. SHENZHEN GREPOW BATTERY
7.9. EPSILOR
7.10. DOOSAN CORPORATION
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY

LIST OF TABLES

TABLE 1: NORTH AMERICA UAV BATTERY MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF ACQUISITIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF INVESTMENTS & EXPANSIONS
TABLE 6: NORTH AMERICA UAV BATTERY MARKET, OUTLOOK BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 7: NORTH AMERICA UAV BATTERY MARKET, OUTLOOK BY UAV MODEL, 2022-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA UAV BATTERY MARKET, OUTLOOK BY INDUSTRY VERTICAL, 2022-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA UAV BATTERY MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: MARKET ATTRACTIVENESS INDEX
FIGURE 2: NORTH AMERICA UAV BATTERY MARKET, OUTLOOK BY PRODUCT TYPE, 2021 & 2028 (IN %)
FIGURE 3: NORTH AMERICA UAV BATTERY MARKET, BY LITHIUM-BASED, 2022-2028 (IN $ MILLION)
FIGURE 4: NORTH AMERICA UAV BATTERY MARKET, BY NICKEL-BASED, 2022-2028 (IN $ MILLION)
FIGURE 5: NORTH AMERICA UAV BATTERY MARKET, BY FUEL CELL, 2022-2028 (IN $ MILLION)
FIGURE 6: NORTH AMERICA UAV BATTERY MARKET, OUTLOOK BY UAV MODEL, 2021 & 2028 (IN %)
FIGURE 7: NORTH AMERICA UAV BATTERY MARKET, BY FIXED-WING, 2022-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA UAV BATTERY MARKET, BY ROTARY-WING, 2022-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA UAV BATTERY MARKET, BY FIXED-WING VTOL (HYBRID), 2022-2028 (IN $ MILLION)
FIGURE 10: NORTH AMERICA UAV BATTERY MARKET, OUTLOOK BY INDUSTRY VERTICAL, 2021 & 2028 (IN %)
FIGURE 11: NORTH AMERICA UAV BATTERY MARKET, BY CONSUMER, 2022-2028 (IN $ MILLION)
FIGURE 12: NORTH AMERICA UAV BATTERY MARKET, BY COMMERCIAL, 2022-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA UAV BATTERY MARKET, BY DEFENSE, GOVERNMENT, & LAW ENFORCEMENT, 2022-2028 (IN $ MILLION)
FIGURE 14: NORTH AMERICA UAV BATTERY MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 15: UNITED STATES UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 16: CANADA UAV BATTERY MARKET 2022-2028 (IN $ MILLION)

The post NORTH AMERICA UAV BATTERY MARKET 2022-2028 first appeared on CRI Report.

According to CRI’s report, the global UAV battery market is deemed to witness growth at a CAGR of 17.46% during the forecast period 2022-2028.
The market is driven by numerous factors, such as advancements in smart battery technology, R&D in UAV and adjacent industries, and the rising need for long-range UAVs with high payload capacity.
However, issues due to thermal runaway and regulations pertaining to UAV battery transport impede the market’s growth. Nevertheless, the adoption of UAVs across industries is anticipated to open new avenues for the UAV battery market.

REGIONAL OUTLOOK

The global UAV battery market covers North America, Asia-Pacific, Latin America, Europe, and the Middle East and Africa regions.
The Asia-Pacific is anticipated to emerge as the fastest-growing region over the forecast period. The rising demand for UAV applications, including deliveries, agriculture, entertainment, and logistics, is expected to drive the demand for UAV batteries to a large extent. Further, advancements in battery technology have increased the demand for long-range and extended battery packs. The investments in battery R&D, including fuel cell and solar power, will support the expansion of the UAV battery market across the region.

COMPETITIVE OUTLOOK

The key companies in the UAV battery market are Plug Power, Intelligent Energy, HES Energy Systems, RRC Power Solutions, Sion Power, Eagle Picher Technologies, Inventus Power, Shenzhen Grepow Battery, Epsilor, and Doosan Corporation.
Plug Power offers zero-emission hydrogen and fuel cell systems. It specializes in the design, development, commercialization, and manufacturing of hydrogen fuel cell devices as an alternative energy source. Additionally, the company is focusing on proton exchange membranes, fuel processing technologies, battery hybrid technologies, and others. Its product line includes GenFuel, ReliOn, and GenDrive. Plug Power has headquarters in the United States.

TABLE OF CONTENTS

1. GLOBAL UAV BATTERY MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE UAV BATTERY MARKET
2.2. KEY INSIGHTS
2.2.1. ADVANCEMENTS IN FUEL CELL TECHNOLOGY
2.2.2. MILITARY INVESTMENTS AND INITIATIVES IN THE UAV SECTOR
2.2.3. POPULARITY OF DRONES IN THE COMMERCIAL INDUSTRY
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. INDUSTRY COMPONENTS
2.7. REGULATORY FRAMEWORK
2.7.1. U.S. REGULATION
2.7.2. OTHER INTERNATIONAL REGULATIONS:
2.8. KEY MARKET STRATEGIES
2.8.1. ACQUISITIONS
2.8.2. PRODUCT LAUNCHES
2.8.3. INVESTMENTS & EXPANSIONS
2.9. MARKET DRIVERS
2.9.1. DEVELOPMENTS IN SMART BATTERY TECHNOLOGY
2.9.2. ONGOING RESEARCH AND DEVELOPMENTS IN UAV AND ADJACENT INDUSTRIES
2.9.3. GROWING NEED FOR LONG-RANGE UAVS WITH HIGH PAYLOAD CAPACITY
2.10. MARKET CHALLENGES
2.10.1. ISSUES DUE TO THERMAL RUNAWAY
2.10.2. REGULATIONS AGAINST TRANSPORT OF UAV BATTERIES
2.11. MARKET OPPORTUNITIES
2.11.1. ADOPTION OF UAVS ACROSS VARIOUS SECTORS
2.11.2. INNOVATIONS IN WIRELESS CHARGING TECHNOLOGY
3. GLOBAL UAV BATTERY MARKET OUTLOOK – BY PRODUCT TYPE
3.1. LITHIUM-BASED
3.2. NICKEL-BASED
3.3. FUEL CELL
4. GLOBAL UAV BATTERY MARKET OUTLOOK – BY UAV MODEL
4.1. FIXED-WING
4.2. ROTARY-WING
4.3. FIXED-WING VTOL (HYBRID)
5. GLOBAL UAV BATTERY MARKET OUTLOOK – BY INDUSTRY VERTICAL
5.1. CONSUMER
5.2. COMMERCIAL
5.3. DEFENSE, GOVERNMENT, & LAW ENFORCEMENT
6. GLOBAL UAV BATTERY MARKET – REGIONAL OUTLOOK
6.1. NORTH AMERICA
6.1.1. MARKET OUTLOOK BY PRODUCT TYPE
6.1.2. MARKET OUTLOOK BY UAV MODEL
6.1.3. MARKET OUTLOOK BY INDUSTRY VERTICAL
6.1.4. COUNTRY ANALYSIS
6.1.4.1. UNITED STATES
6.1.4.2. CANADA
6.2. EUROPE
6.2.1. MARKET OUTLOOK BY PRODUCT TYPE
6.2.2. MARKET OUTLOOK BY UAV MODEL
6.2.3. MARKET OUTLOOK BY INDUSTRY VERTICAL
6.2.4. COUNTRY ANALYSIS
6.2.4.1. UNITED KINGDOM
6.2.4.2. GERMANY
6.2.4.3. FRANCE
6.2.4.4. SPAIN
6.2.4.5. ITALY
6.2.4.6. POLAND
6.2.4.7. REST OF EUROPE
6.3. ASIA-PACIFIC
6.3.1. MARKET OUTLOOK BY PRODUCT TYPE
6.3.2. MARKET OUTLOOK BY UAV MODEL
6.3.3. MARKET OUTLOOK BY INDUSTRY VERTICAL
6.3.4. COUNTRY ANALYSIS
6.3.4.1. CHINA
6.3.4.2. JAPAN
6.3.4.3. INDIA
6.3.4.4. SOUTH KOREA
6.3.4.5. ASEAN COUNTRIES
6.3.4.6. AUSTRALIA & NEW ZEALAND
6.3.4.7. REST OF ASIA-PACIFIC
6.4. LATIN AMERICA
6.4.1. MARKET OUTLOOK BY PRODUCT TYPE
6.4.2. MARKET OUTLOOK BY UAV MODEL
6.4.3. MARKET OUTLOOK BY INDUSTRY VERTICAL
6.4.4. COUNTRY ANALYSIS
6.4.4.1. BRAZIL
6.4.4.2. MEXICO
6.4.4.3. REST OF LATIN AMERICA
6.5. MIDDLE EAST AND AFRICA
6.5.1. MARKET OUTLOOK BY PRODUCT TYPE
6.5.2. MARKET OUTLOOK BY UAV MODEL
6.5.3. MARKET OUTLOOK BY INDUSTRY VERTICAL
6.5.4. COUNTRY ANALYSIS
6.5.4.1. UNITED ARAB EMIRATES
6.5.4.2. SAUDI ARABIA
6.5.4.3. TURKEY
6.5.4.4. SOUTH AFRICA
6.5.4.5. REST OF MIDDLE EAST & AFRICA
7. COMPETITIVE LANDSCAPE
7.1. PLUG POWER
7.2. INTELLIGENT ENERGY
7.3. HES ENERGY SYSTEMS
7.4. RRC POWER SOLUTIONS
7.5. SION POWER
7.6. EAGLE PICHER TECHNOLOGIES
7.7. INVENTUS POWER
7.8. SHENZHEN GREPOW BATTERY
7.9. EPSILOR
7.10. DOOSAN CORPORATION
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY

LIST OF TABLES

TABLE 1: GLOBAL UAV BATTERY MARKET, REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF ACQUISITIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF INVESTMENTS & EXPANSIONS
TABLE 6: GLOBAL UAV BATTERY MARKET, OUTLOOK BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 7: GLOBAL UAV BATTERY MARKET, OUTLOOK BY UAV MODEL, 2022-2028 (IN $ MILLION)
TABLE 8: GLOBAL UAV BATTERY MARKET, OUTLOOK BY INDUSTRY VERTICAL, 2022-2028 (IN $ MILLION)
TABLE 9: GLOBAL UAV BATTERY MARKET, REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA UAV BATTERY MARKET, OUTLOOK BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 11: NORTH AMERICA UAV BATTERY MARKET, OUTLOOK BY UAV MODEL, 2022-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA UAV BATTERY MARKET, OUTLOOK BY INDUSTRY VERTICAL, 2022-2028 (IN $ MILLION)
TABLE 13: NORTH AMERICA UAV BATTERY MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 14: EUROPE UAV BATTERY MARKET, OUTLOOK BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 15: EUROPE UAV BATTERY MARKET, OUTLOOK BY UAV MODEL, 2022-2028 (IN $ MILLION)
TABLE 16: EUROPE UAV BATTERY MARKET, OUTLOOK BY INDUSTRY VERTICAL, 2022-2028 (IN $ MILLION)
TABLE 17: EUROPE UAV BATTERY MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 18: ASIA-PACIFIC UAV BATTERY MARKET, OUTLOOK BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 19: ASIA-PACIFIC UAV BATTERY MARKET, OUTLOOK BY UAV MODEL, 2022-2028 (IN $ MILLION)
TABLE 20: ASIA-PACIFIC UAV BATTERY MARKET, OUTLOOK BY INDUSTRY VERTICAL, 2022-2028 (IN $ MILLION)
TABLE 21: ASIA-PACIFIC UAV BATTERY MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 22: LATIN AMERICA UAV BATTERY MARKET, OUTLOOK BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 23: LATIN AMERICA UAV BATTERY MARKET, OUTLOOK BY UAV MODEL, 2022-2028 (IN $ MILLION)
TABLE 24: LATIN AMERICA UAV BATTERY MARKET, OUTLOOK BY INDUSTRY VERTICAL, 2022-2028 (IN $ MILLION)
TABLE 25: LATIN AMERICA UAV BATTERY MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 26: MIDDLE EAST AND AFRICA UAV BATTERY MARKET, OUTLOOK BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 27: MIDDLE EAST AND AFRICA UAV BATTERY MARKET, OUTLOOK BY UAV MODEL, 2022-2028 (IN $ MILLION)
TABLE 28: MIDDLE EAST AND AFRICA UAV BATTERY MARKET, OUTLOOK BY INDUSTRY VERTICAL, 2022-2028 (IN $ MILLION)
TABLE 29: MIDDLE EAST AND AFRICA UAV BATTERY MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: MARKET ATTRACTIVENESS INDEX
FIGURE 2: GLOBAL UAV BATTERY MARKET, OUTLOOK BY PRODUCT TYPE, 2021 & 2028 (IN %)
FIGURE 3: GLOBAL UAV BATTERY MARKET, BY LITHIUM-BASED, 2022-2028 (IN $ MILLION)
FIGURE 4: GLOBAL UAV BATTERY MARKET, BY NICKEL-BASED, 2022-2028 (IN $ MILLION)
FIGURE 5: GLOBAL UAV BATTERY MARKET, BY FUEL CELL, 2022-2028 (IN $ MILLION)
FIGURE 6: GLOBAL UAV BATTERY MARKET, OUTLOOK BY UAV MODEL, 2021 & 2028 (IN %)
FIGURE 7: GLOBAL UAV BATTERY MARKET, BY FIXED-WING, 2022-2028 (IN $ MILLION)
FIGURE 8: GLOBAL UAV BATTERY MARKET, BY ROTARY-WING, 2022-2028 (IN $ MILLION)
FIGURE 9: GLOBAL UAV BATTERY MARKET, BY FIXED-WING VTOL (HYBRID), 2022-2028 (IN $ MILLION)
FIGURE 10: GLOBAL UAV BATTERY MARKET, OUTLOOK BY INDUSTRY VERTICAL, 2021 & 2028 (IN %)
FIGURE 11: GLOBAL UAV BATTERY MARKET, BY CONSUMER, 2022-2028 (IN $ MILLION)
FIGURE 12: GLOBAL UAV BATTERY MARKET, BY COMMERCIAL, 2022-2028 (IN $ MILLION)
FIGURE 13: GLOBAL UAV BATTERY MARKET, BY DEFENSE, GOVERNMENT, & LAW ENFORCEMENT, 2022-2028 (IN $ MILLION)
FIGURE 14: GLOBAL UAV BATTERY MARKET, REGIONAL OUTLOOK, 2021 & 2028 (IN %)
FIGURE 15: NORTH AMERICA UAV BATTERY MARKET COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 16: UNITED STATES UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 17: CANADA UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 18: EUROPE UAV BATTERY MARKET COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 19: UNITED KINGDOM UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 20: GERMANY UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 21: FRANCE UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 22: SPAIN UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: ITALY UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: POLAND UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 25: REST OF EUROPE UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: ASIA-PACIFIC UAV BATTERY MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 27: CHINA UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 28: JAPAN UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 29: INDIA UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 30: SOUTH KOREA UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 31: ASEAN COUNTRIES UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 32: AUSTRALIA & NEW ZEALAND UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 33: REST OF ASIA-PACIFIC UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 34: LATIN AMERICA UAV BATTERY MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 35: BRAZIL UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 36: MEXICO UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 37: REST OF LATIN AMERICA UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 38: MIDDLE EAST & AFRICA UAV BATTERY MARKET, COUNTRY OUTLOOK, 2021
FIGURE 39: UNITED ARAB EMIRATES UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 40: SAUDI ARABIA UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 41: TURKEY UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 42: SOUTH AFRICA UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 43: REST OF MIDDLE EAST & AFRICA UAV BATTERY MARKET 2022-2028 (IN $ MILLION)

The post GLOBAL UAV BATTERY MARKET 2022-2028 first appeared on CRI Report.

CRI’s report suggests that the Middle East and Africa UAV battery market is deemed to advance at a compound annual growth rate of 16.06% during the forecasting period 2022-2028. Saudi Arabia, South Africa, the UAE, Turkey, and Rest of Middle East & Africa are studied in the region’s market.

In the United Arab Emirates, the government has made significant investments in expanding its armed forces’ capabilities. Moreover, it has managed to create one of the most advanced militaries in the region, operating with high-level air capabilities compared to other Gulf nations.

The nation’s interest in unmanned aerial vehicles surfaced in 2013 when it signed a contract with General Atomics to procure MQ-1 Predator XP Aircraft and associated ground systems. Additionally, the country is communicating with Turkish drone maker Baykar to acquire 120 TB2 drones. Such developments are anticipated to augment the UAV battery market’s growth.

Saudi Arabia, on the other hand, permits the use of only registered drones. Although the nation has among the most advanced air forces in the region, it has only a few weaponized drones. Nevertheless, the country has stated its plans to work with Chinese products to develop its line of armed drones. Unmanned aircraft systems have become a beneficial technology across several other industries.

This has led the nation to actively invest in the production of drones to diversify its revenue streams. Thus, the increase in the production of drone technology is expected to boost Saudi Arabia’s UAV battery market.

COMPETITIVE OUTLOOK

The key companies in the UAV battery market consist of Intelligent Energy, Epsilor, Plug Power, RRC Power Solutions, and Doosan Corporation.

TABLE OF CONTENTS

1. MIDDLE EAST AND AFRICA UAV BATTERY MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE UAV BATTERY MARKET
2.2. KEY INSIGHTS
2.2.1. ADVANCEMENTS IN FUEL CELL TECHNOLOGY
2.2.2. MILITARY INVESTMENTS AND INITIATIVES IN THE UAV SECTOR
2.2.3. POPULARITY OF DRONES IN THE COMMERCIAL INDUSTRY
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. INDUSTRY COMPONENTS
2.7. REGULATORY FRAMEWORK
2.8. KEY MARKET STRATEGIES
2.8.1. ACQUISITIONS
2.8.2. PRODUCT LAUNCHES
2.8.3. INVESTMENTS & EXPANSIONS
2.9. MARKET DRIVERS
2.9.1. DEVELOPMENTS IN SMART BATTERY TECHNOLOGY
2.9.2. ONGOING RESEARCH AND DEVELOPMENTS IN UAV AND ADJACENT INDUSTRIES
2.9.3. GROWING NEED FOR LONG-RANGE UAVS WITH HIGH PAYLOAD CAPACITY
2.10. MARKET CHALLENGES
2.10.1. ISSUES DUE TO THERMAL RUNAWAY
2.10.2. REGULATIONS AGAINST TRANSPORT OF UAV BATTERIES
2.11. MARKET OPPORTUNITIES
2.11.1. ADOPTION OF UAVS ACROSS VARIOUS SECTORS
2.11.2. INNOVATIONS IN WIRELESS CHARGING TECHNOLOGY
3. MIDDLE EAST AND AFRICA UAV BATTERY MARKET OUTLOOK – BY PRODUCT TYPE
3.1. LITHIUM-BASED
3.2. NICKEL-BASED
3.3. FUEL CELL
4. MIDDLE EAST AND AFRICA UAV BATTERY MARKET OUTLOOK – BY UAV MODEL
4.1. FIXED-WING
4.2. ROTARY-WING
4.3. FIXED-WING VTOL (HYBRID)
5. MIDDLE EAST AND AFRICA UAV BATTERY MARKET OUTLOOK – BY INDUSTRY VERTICAL
5.1. CONSUMER
5.2. COMMERCIAL
5.3. DEFENSE, GOVERNMENT, & LAW ENFORCEMENT
6. MIDDLE EAST AND AFRICA UAV BATTERY MARKET – COUNTRY OUTLOOK
6.1. UNITED ARAB EMIRATES
6.2. SAUDI ARABIA
6.3. TURKEY
6.4. SOUTH AFRICA
6.5. REST OF MIDDLE EAST & AFRICA
7. COMPETITIVE LANDSCAPE
7.1. PLUG POWER
7.2. INTELLIGENT ENERGY
7.3. HES ENERGY SYSTEMS
7.4. RRC POWER SOLUTIONS
7.5. SION POWER
7.6. EAGLE PICHER TECHNOLOGIES
7.7. INVENTUS POWER
7.8. SHENZHEN GREPOW BATTERY
7.9. EPSILOR
7.10. DOOSAN CORPORATION
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY

LIST OF TABLES

TABLE 1: MIDDLE EAST AND AFRICA UAV BATTERY MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF ACQUISITIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF INVESTMENTS & EXPANSIONS
TABLE 6: MIDDLE EAST AND AFRICA UAV BATTERY MARKET, OUTLOOK BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 7: MIDDLE EAST AND AFRICA UAV BATTERY MARKET, OUTLOOK BY UAV MODEL, 2022-2028 (IN $ MILLION)
TABLE 8: MIDDLE EAST AND AFRICA UAV BATTERY MARKET, OUTLOOK BY INDUSTRY VERTICAL, 2022-2028 (IN $ MILLION)
TABLE 9: MIDDLE EAST AND AFRICA UAV BATTERY MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: MARKET ATTRACTIVENESS INDEX
FIGURE 2: MIDDLE EAST AND AFRICA UAV BATTERY MARKET, OUTLOOK BY PRODUCT TYPE, 2021 & 2028 (IN %)
FIGURE 3: MIDDLE EAST AND AFRICA UAV BATTERY MARKET, BY LITHIUM-BASED, 2022-2028 (IN $ MILLION)
FIGURE 4: MIDDLE EAST AND AFRICA UAV BATTERY MARKET, BY NICKEL-BASED, 2022-2028 (IN $ MILLION)
FIGURE 5: MIDDLE EAST AND AFRICA UAV BATTERY MARKET, BY FUEL CELL, 2022-2028 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND AFRICA UAV BATTERY MARKET, OUTLOOK BY UAV MODEL, 2021 & 2028 (IN %)
FIGURE 7: MIDDLE EAST AND AFRICA UAV BATTERY MARKET, BY FIXED-WING, 2022-2028 (IN $ MILLION)
FIGURE 8: MIDDLE EAST AND AFRICA UAV BATTERY MARKET, BY ROTARY-WING, 2022-2028 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND AFRICA UAV BATTERY MARKET, BY FIXED-WING VTOL (HYBRID), 2022-2028 (IN $ MILLION)
FIGURE 10: MIDDLE EAST AND AFRICA UAV BATTERY MARKET, OUTLOOK BY INDUSTRY VERTICAL, 2021 & 2028 (IN %)
FIGURE 11: MIDDLE EAST AND AFRICA UAV BATTERY MARKET, BY CONSUMER, 2022-2028 (IN $ MILLION)
FIGURE 12: MIDDLE EAST AND AFRICA UAV BATTERY MARKET, BY COMMERCIAL, 2022-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND AFRICA UAV BATTERY MARKET, BY DEFENSE, GOVERNMENT & LAW ENFORCEMENT, 2022-2028 (IN $ MILLION)
FIGURE 14: MIDDLE EAST AND AFRICA UAV BATTERY MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 15: UNITED ARAB EMIRATES UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 16: SAUDI ARABIA UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 17: TURKEY UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 18: SOUTH AFRICA UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 19: REST OF MIDDLE EAST & AFRICA UAV BATTERY MARKET 2022-2028 (IN $ MILLION)

The post MIDDLE EAST AND AFRICA UAV BATTERY MARKET 2022-2028 first appeared on CRI Report.

CRI’s report insinuates that the UAV battery market in Europe is estimated to advance at a CAGR of 16.60% in value during the forecast years 2022-2028. France, Germany, Italy, Spain, Poland, the United Kingdom, and the Rest of Europe are studied in the given region.
In recent years, the UK has emerged as one of the most lucrative countries for investments in UAVs. This is mainly because the country shows immense potential in developing next generation UAVs for various industry verticals, including defense and security. In 2019, the country’s defense secretary authorized funding of a drone project to enhance defense capabilities, further increasing UAV batteries’ adoption.
Furthermore, drones have gained significant prominence for various applications, from infrastructure project inspection to wedding photography. This has encouraged UAV manufacturers to expand their footing in the UK UAV battery market.
Spain, on the other hand, has emerged as a pioneer in the development of unmanned aerial vehicles. From agriculture to e-commerce to energy, UAV applications have widened over recent years. As per estimates, around 1500 drone-related development initiatives are underway in the country. Thus, such developments are expected to generate lucrative opportunities for the UAV battery market.

COMPETITIVE OUTLOOK

The leading companies in the UAV battery market are Plug Power, Intelligent Energy, Sion Power, Epsilor, Doosan Corporation, and HES Energy Systems.

TABLE OF CONTENTS

1. EUROPE UAV BATTERY MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE UAV BATTERY MARKET
2.2. KEY INSIGHTS
2.2.1. ADVANCEMENTS IN FUEL CELL TECHNOLOGY
2.2.2. MILITARY INVESTMENTS AND INITIATIVES IN THE UAV SECTOR
2.2.3. POPULARITY OF DRONES IN THE COMMERCIAL INDUSTRY
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. INDUSTRY COMPONENTS
2.7. REGULATORY FRAMEWORK
2.8. KEY MARKET STRATEGIES
2.8.1. ACQUISITIONS
2.8.2. PRODUCT LAUNCHES
2.8.3. INVESTMENTS & EXPANSIONS
2.9. MARKET DRIVERS
2.9.1. DEVELOPMENTS IN SMART BATTERY TECHNOLOGY
2.9.2. ONGOING RESEARCH AND DEVELOPMENTS IN UAV AND ADJACENT INDUSTRIES
2.9.3. GROWING NEED FOR LONG-RANGE UAVS WITH HIGH PAYLOAD CAPACITY
2.10. MARKET CHALLENGES
2.10.1. ISSUES DUE TO THERMAL RUNAWAY
2.10.2. REGULATIONS AGAINST TRANSPORT OF UAV BATTERIES
2.11. MARKET OPPORTUNITIES
2.11.1. ADOPTION OF UAVS ACROSS VARIOUS SECTORS
2.11.2. INNOVATIONS IN WIRELESS CHARGING TECHNOLOGY
3. EUROPE UAV BATTERY MARKET OUTLOOK – BY PRODUCT TYPE
3.1. LITHIUM-BASED
3.2. NICKEL-BASED
3.3. FUEL CELL
4. EUROPE UAV BATTERY MARKET OUTLOOK – BY UAV MODEL
4.1. FIXED-WING
4.2. ROTARY-WING
4.3. FIXED-WING VTOL (HYBRID)
5. EUROPE UAV BATTERY MARKET OUTLOOK – BY INDUSTRY VERTICAL
5.1. CONSUMER
5.2. COMMERCIAL
5.3. DEFENSE, GOVERNMENT, & LAW ENFORCEMENT
6. EUROPE UAV BATTERY MARKET – COUNTRY OUTLOOK
6.1. UNITED KINGDOM
6.2. GERMANY
6.3. FRANCE
6.4. SPAIN
6.5. ITALY
6.6. POLAND
6.7. REST OF EUROPE
7. COMPETITIVE LANDSCAPE
7.1. PLUG POWER
7.2. INTELLIGENT ENERGY
7.3. HES ENERGY SYSTEMS
7.4. RRC POWER SOLUTIONS
7.5. SION POWER
7.6. EAGLE PICHER TECHNOLOGIES
7.7. INVENTUS POWER
7.8. SHENZHEN GREPOW BATTERY
7.9. EPSILOR
7.10. DOOSAN CORPORATION
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY

LIST OF TABLES

TABLE 1: EUROPE UAV BATTERY MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF ACQUISITIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF INVESTMENTS & EXPANSIONS
TABLE 6: EUROPE UAV BATTERY MARKET, OUTLOOK BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 7: EUROPE UAV BATTERY MARKET, OUTLOOK BY UAV MODEL, 2022-2028 (IN $ MILLION)
TABLE 8: EUROPE UAV BATTERY MARKET, OUTLOOK BY INDUSTRY VERTICAL, 2022-2028 (IN $ MILLION)
TABLE 9: EUROPE UAV BATTERY MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: MARKET ATTRACTIVENESS INDEX
FIGURE 2: EUROPE UAV BATTERY MARKET, OUTLOOK BY PRODUCT TYPE, 2021 & 2028 (IN %)
FIGURE 3: EUROPE UAV BATTERY MARKET, BY LITHIUM-BASED, 2022-2028 (IN $ MILLION)
FIGURE 4: EUROPE UAV BATTERY MARKET, BY NICKEL-BASED, 2022-2028 (IN $ MILLION)
FIGURE 5: EUROPE UAV BATTERY MARKET, BY FUEL CELL, 2022-2028 (IN $ MILLION)
FIGURE 6: EUROPE UAV BATTERY MARKET, OUTLOOK BY UAV MODEL, 2021 & 2028 (IN %)
FIGURE 7: EUROPE UAV BATTERY MARKET, BY FIXED-WING, 2022-2028 (IN $ MILLION)
FIGURE 8: EUROPE UAV BATTERY MARKET, BY ROTARY-WING, 2022-2028 (IN $ MILLION)
FIGURE 9: EUROPE UAV BATTERY MARKET, BY FIXED-WING VTOL (HYBRID), 2022-2028 (IN $ MILLION)
FIGURE 10: EUROPE UAV BATTERY MARKET, OUTLOOK BY INDUSTRY VERTICAL, 2021 & 2028 (IN %)
FIGURE 11: EUROPE UAV BATTERY MARKET, BY CONSUMER, 2022-2028 (IN $ MILLION)
FIGURE 12: EUROPE UAV BATTERY MARKET, BY COMMERCIAL, 2022-2028 (IN $ MILLION)
FIGURE 13: EUROPE UAV BATTERY MARKET, BY DEFENSE, GOVERNMENT, & LAW ENFORCEMENT, 2022-2028 (IN $ MILLION)
FIGURE 14: EUROPE UAV BATTERY MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 15: UNITED KINGDOM UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 16: GERMANY UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 17: FRANCE UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 18: SPAIN UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 19: ITALY UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 20: POLAND UAV BATTERY MARKET 2022-2028 (IN $ MILLION)
FIGURE 21: REST OF EUROPE UAV BATTERY MARKET 2022-2028 (IN $ MILLION)

The post EUROPE UAV BATTERY MARKET 2022-2028 first appeared on CRI Report.